Literature DB >> 8739582

Prenatal spinal evaluation and functional outcome of patients born with myelomeningocele: information for improved prenatal counselling and outcome prediction.

D D Cochrane1, R D Wilson, P Steinbok, D F Farquharson, B Irwin, B Irvine, K Chambers.   

Abstract

OBJECTIVE: Prenatal ultrasonography can localize the level of the spinal cord malformation, allowing prediction of the potential postnatal neurological deficit and functional prognosis.
METHODS: This study has two evaluations: (a) a retrospective prenatal review of 26 fetuses with spinal dysraphism (1987-1991), and (b) a follow-up descriptive study of patients (1971-1981) who underwent closure of the spinal lesion and ventricular shunting in the neonatal period.
RESULTS: Prenatal ultrasound evaluation enabled the accurate definition of the last intact vertebral level which allows separation of fetuses into three functional groups (last intact level L2, L3-4, L5-sacral). Patterns of ambulation, urinary and bowel continence, and school performance vary according to level of spinal lesion and the neurological deficit. The need for ventricular shunts, the incidence of other spinal malformations and surgical interventions did not vary with the level of the spinal lesion.
CONCLUSIONS: The functional outcome for patients with myelomeningocele is variable; however, distinct patterns emerge based on the level of spinal dysraphism and the resultant neurological deficit. By relating the level of the fetal spinal lesion to outcome data, more precise functional prognoses can be given to families.

Entities:  

Mesh:

Year:  1996        PMID: 8739582     DOI: 10.1159/000264297

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  9 in total

1.  The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia.

Authors:  Margot I Van Allen; Erin Boyle; Paul Thiessen; Deborah McFadden; Douglas Cochrane; G Keith Chambers; Sylvie Langlois; Patricia Stathers; Beverly Irwin; Elizabeth Cairns; Patrick MacLeod; Marie-France Delisle; Soo-Hong Uh
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

2.  Update and Review: Maternal Serum Screening.

Authors:  K E Ormond
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

3.  Fetal surgery for myelomeningocele: trials and tribulations. Isabella Forshall Lecture.

Authors:  N Scott Adzick
Journal:  J Pediatr Surg       Date:  2012-02       Impact factor: 2.545

Review 4.  Fetal surgery for spina bifida: past, present, future.

Authors:  N Scott Adzick
Journal:  Semin Pediatr Surg       Date:  2013-02       Impact factor: 2.754

Review 5.  Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention.

Authors:  N Scott Adzick
Journal:  Semin Fetal Neonatal Med       Date:  2009-06-18       Impact factor: 3.926

6.  Fetal surgery for myelomeningocele.

Authors:  Leslie N Sutton; N Scott Adzick; Mark P Johnson
Journal:  Childs Nerv Syst       Date:  2003-07-15       Impact factor: 1.475

7.  Perinatal and Neonatal Outcomes of Patients Who Were Diagnosed with Neural Tube Defect in Midtrimester Fetal Ultrasound Scan and Refused Request for Termination of Pregnancy.

Authors:  Rauf Melekoglu; Sevil Eraslan; Ebru Celik; Yavuz Simsek
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

8.  Ascent of the conus medullaris in human foetuses: a systematic review and meta-analysis.

Authors:  Lucas Costa Almeida; Yasmin Juliany de Souza Figueiredo; André Pinheiro Zylberman; Diogo Costa Garção
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

9.  Myelomeningocele-Chiari II malformation-Neurological predictability based on fetal and postnatal magnetic resonance imaging.

Authors:  Farjad Khalaveh; Rainer Seidl; Thomas Czech; Andrea Reinprecht; Gerlinde Maria Gruber; Angelika Berger; Herbert Kiss; Daniela Prayer; Gregor Kasprian
Journal:  Prenat Diagn       Date:  2021-06-19       Impact factor: 3.050

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.